LY3405105 is a novel, potent, and selective inhibitor of cyclin-dependent kinase 7 (CDK7). This small molecule is used in biochemical and cellular research to investigate CDK7s roles in transcription and cell cycle progression, with studies demonstrating its activity in both in vitro assays and in vivo cancer models.
Molekulargewicht:
497.63
Reinheit:
99.66% (May vary between batches)
CAS Nummer:
[2326428-25-3]
Formel:
C26H39N7O3
Target-Kategorie:
CDK
Anwendungsbeschreibung:
Solubility: DMSO:4.98 mg/mL (10.01 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten